Reltio’s first customers were life sciences and pharmaceutical companies. In fact, 9 of the Top 10 Pharma companies use Reltio Connected Data Platform for drug Research & Development, commercialization, direct-to-consumer marketing, and distribution management (sales & marketing). We understand the data you need to be successful. And we have been delivering it to our customers on a cloud-native, multi-domain master data management (MDM) software as a service platform for nearly 7 years.
Connected Graph technology is unique to Reltio Enterprise 360 Site Intelligence. PIs, study sites, HCOs, and HCPs are often connected in many-to-many relationships. Graph reveals valuable insights that traditional databases cannot. Graph technology can quickly identify content preferences, influence in a disease area, prescribed products, and clinical trial participation. The graph helps model inter-relationships and dynamic hierarchical information for an at-a-glance view.
AI provides insight into key considerations for Clinical Trials. These include Study Site and PI performance on past studies, relationships with competitors, areas of expertise, site logistics, and other important data.